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Introduction
Several circumstances contribute to the greater propensity
for adverse drug reactions (ADRs) in the elderly, including
use of multiple drugs and pharmacokinetic and pharmaco-
dynamic alterations intrinsic to aging. We sought to evalu-
ate the characteristics of ADRs in the elderly compared
with younger adults.
Methods
ADRs were collected from a spontaneous reporting system
at Seoul National University Hospital from February 2010
to September 2013. We analyzed causative drugs, clinical
manifestations and severity of ADRs.
Results
A total of 15,541 ADRs was reported in patients greater
than or equal to 18 years. Common causative drug cate-
gory included nervous system, neoplastic, anti-infectives.
The prevalence of ADRs due to respiratory drugs and
cardiovascular drugs was higher in the elderly group
(¡Ã 60 years) than in other groups. The most prevalent
clinical types were gastrointestinal disorders and skin and
appendage disorders. Psychiatric disorder, cardiovascular
disorder, hematologic disorder and genitourinary disorder
were more prevalent in the elderly group than in other
groups. The proportions of severe ADRs were higher in
the elderly groups or in male patients.
Conclusions
Elderly patients seemed to be more susceptible to ADRs.
Further efforts to understand, management and prevent
the ADRs in the elderly are required.
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